期刊
NEPHROLOGY DIALYSIS TRANSPLANTATION
卷 35, 期 3, 页码 438-446出版社
OXFORD UNIV PRESS
DOI: 10.1093/ndt/gfy403
关键词
chronic kidney disease; FGF-23; phosphate; prognosis; proteinuria
资金
- Korea Centers for Disease Control and Prevention [2011E3300300, 2012E3301100, 2013E3301600, 2013E3301601, 2013E3301602, 2016E3300200]
Background. Recent experimental study reported that proteinuria increases serum phosphate by decreasing biologic activity of fibroblast growth factor 23 (FGF-23). We examined this relationship in a large chronic kidney disease (CKD) cohort and evaluated the combined effect of proteinuria, FGF-23 activity and serum phosphate on CKD progression. Methods. The activity of FGF-23, measured by the fractional excretion of phosphate (FEP)/FGF-23 ratio, was compared according to the degree of proteinuria in 1909 patients with CKD. Primary outcome was CKD progression defined as >= 50% decline of estimated glomerular filtration rate, doubling of serum creatinine and start of dialysis. Results. There was a negative relationship between 24-h urine protein (24-h UP) and FEP/FGF-23 ratio (gamma -0.07; P=0.005). In addition, after matching variables associated with serum phosphate, patients with more proteinuria had higher serum phosphate (P<0.001) and FGF-23 (P=0.012), and lower FEP/FGF-23 ratio (P=0.007) compared with those with less proteinuria. In the matched cohort, low FEP/FGF-23 ratio was an independent risk factor for CKD progression (hazard ratio 0.87 per 1 log increase; 95% confidence interval 0.79-0.95; P=0.002), and there was significant interaction between 24-h UP and FEP/FGF-23 ratio (P=0.039). Furthermore, 24-h UP and serum phosphate also had a significant interaction on CKD progression (P<0.001). Conclusions. Proteinuria is associated with decreased biologic activity of FGF-23 and increased serum phosphate. Furthermore, diminished activity of FGF23 is an independent risk factor for renal progression in proteinuric CKD patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据